Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which impacted the stock price prior to a merger announcement with AbbVie Inc. [1][2] Group 1: Allegations and Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, which artificially deflated Cerevel's stock price until the merger was announced [2] - Bain Capital, Cerevel's controlling shareholder, reportedly acquired shares at the depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2] - Cerevel's January 18, 2024 Proxy statement is claimed to have misled investors regarding the nature and timing of AbbVie's interest in the company [2] Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1] - The deadline for shareholders to register for the class action is June 3, 2025, and there is no cost or obligation to participate [3] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3] Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [4] - The firm seeks recovery for investors who incurred losses from misleading statements or omissions that led to artificial inflation of stock prices [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Atkore Inc. regarding a class action lawsuit alleging anticompetitive practices, specifically price-fixing of PVC Pipes, which led to misleading statements about the company's financial health and operations [1]. Group 1: Allegations and Impact - The complaint alleges that Atkore engaged in a price-fixing scheme that artificially inflated the price of PVC Pipes [1]. - Atkore reportedly gained significant and unsustainable financial benefits from this anticompetitive conduct [1]. - As the price-fixing scheme was exposed, the ability to maintain inflated prices resulted in a substantial decrease in PVC Pipe prices, negatively impacting Atkore's business and operations [1]. - The positive statements made by Atkore regarding its business and prospects were claimed to be materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from August 2, 2022, to February 3, 2025, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is April 23, 2025, and there is no cost or obligation to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Elastic N.V. regarding a class action lawsuit due to alleged misleading statements and operational disruptions affecting sales during FY 2025 [1]. Group 1: Allegations - The complaint alleges that Elastic made materially false and misleading statements and failed to disclose significant changes to its sales operations, particularly in the Americas [1]. - These changes reportedly disrupted Elastic's sales operations in the first quarter of FY 2025, leading to an overstatement of the stability of its sales operations [1]. - As a result, Elastic is unlikely to meet its previously issued revenue guidance for FY 2025, making the defendants' public statements materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from May 31, 2024, to August 29, 2024, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is April 14, 2025, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Perpetua Resources Corp. regarding a class action lawsuit due to significant increases in capital expenditure for the Stibnite Gold Project, which led to a substantial decline in the company's stock price [1][2]. Summary by Sections Class Action Details - Shareholders who purchased shares of Perpetua Resources Corp. (NASDAQ: PPTA) between April 17, 2024, and February 13, 2025, are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1][2]. - The lawsuit alleges that the company misrepresented the expected initial capital expenditure for the Stibnite Gold Project, downplaying the impact of inflation and other cost increases [2]. Financial Impact - On February 13, 2025, Perpetua disclosed an updated cash flow model revealing additional capital expenses of $952 million, representing a more than 75% increase from initial estimates [2]. - Following this announcement, Perpetua's stock price plummeted from $11.97 per share to $9.29 per share on February 14, 2025, marking a decline of approximately 22.39% in one day [2]. Next Steps for Shareholders - The deadline for shareholders to register for the class action is May 20, 2025, and there is no cost or obligation to participate [3]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [3]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Maravai LifeSciences Holdings, Inc. regarding a class action lawsuit due to allegations of misleading statements and inadequate internal controls over financial reporting [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from August 7, 2024, to February 24, 2025 [1]. - Allegations include that Maravai lacked adequate internal controls over financial reporting related to revenue recognition, leading to inaccurate revenue recognition during fiscal 2024 [1]. - The complaint also states that the company's goodwill was overstated, and positive statements made by defendants about the company's business were materially misleading [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by May 5, 2025, to potentially become lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its business practices, particularly concerning inflated revenue and improper claims submissions [1][2]. Allegations - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue figures [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including potential removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants about Zynex's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the lawsuit is from March 13, 2023, to March 11, 2025 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action by May 19, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the lifecycle of the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=140443&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

Core Viewpoint - The Trade Desk, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, and its impact on the company's business operations and revenue growth [3][4]. Summary by Sections Class Action Details - The class period for the lawsuit is from May 9, 2024, to February 12, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1][4]. Allegations Against The Trade Desk - The complaint alleges that The Trade Desk faced significant execution challenges in rolling out its AI tool, Kokai, which included difficulties in transitioning clients from the older platform, Solimar [3]. - These execution challenges delayed the rollout of Kokai and negatively impacted the company's business operations, particularly revenue growth [3]. - The positive statements made by the company regarding its business and prospects were claimed to be materially false and misleading due to these issues [3]. Next Steps for Shareholders - Shareholders are advised to register for the class action by April 21, 2025, to participate in the case without any cost or obligation [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4]. About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Merck & Co., Inc. regarding a class action lawsuit related to misleading statements about the company's expected revenue from Gardasil sales by 2030 [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Merck's management provided investors with optimistic forecasts, claiming expected revenue of $11 billion from Gardasil sales by 2030, driven by successful consumer activation and education efforts [3]. - The truth emerged on February 4, 2025, when Merck announced it would not achieve the projected $11 billion in sales, ceasing shipments of Gardasil to China to reduce inventory due to lower-than-expected demand [3]. - Following this announcement, Merck's stock price fell from $99.79 per share on February 3, 2025, to $90.74 per share on February 4, 2025, marking a decline of over 9% in one day [3]. Next Steps for Shareholders - Shareholders who purchased shares of MRK during the specified class period are encouraged to register for the class action by April 14, 2025, to potentially become lead plaintiffs [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4]. Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Merck & Co., Inc. regarding a class action lawsuit related to misleading statements about Gardasil's expected revenue, which has led to significant stock price declines [1]. Group 1: Allegations and Impact - The lawsuit alleges that Merck provided investors with material information indicating expected revenue of $11 billion from Gardasil sales by 2030, driven by consumer activation and education efforts [1]. - On February 4, 2025, Merck announced it would not achieve the projected $11 billion in sales, ceasing shipments to China to reduce inventory due to lower-than-expected demand, resulting in a stock price drop from $99.79 to $90.74, a decline of over 9% in one day [1]. Group 2: Class Action Details - Shareholders who purchased MRK shares during the class period from February 3, 2022, to February 3, 2025, are encouraged to register for the class action, with a deadline of April 14, 2025, to seek lead plaintiff status [2]. - Registered shareholders will receive updates through portfolio monitoring software throughout the case lifecycle, with no cost or obligation to participate [2]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3].